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Abstract
Given the importance of the transcriptional regulator hypoxia-inducible factor-1 (HIF-1) for adaptive hypoxia responses, we examined the effect of stabilized HIF-1a on renal epithelial permeability and directed sodium transport.
This study was motivated by histological analysis of cystic kidneys showing
increased expression levels of HIF-1a and HIF-2a. We hypothesize that compression induced localized ischemia-hypoxia of normal epithelia near a cyst
leads to local stabilization of HIF-1a, leading to altered transepithelial transport that encourages cyst expansion. We found that stabilized HIF-1a alters
both transcellular and paracellular transport through renal epithelial monolayers in a manner consistent with secretory behavior, indicating localized ischemia-hypoxia may lead to altered salt and water transport through kidney
epithelial monolayers. A quantity of 100 lmol/L Cobalt chloride (CoCl2) was
used acutely to stabilize HIF-1a in confluent cultures of mouse renal epithelia.
We measured increased transepithelial permeability and decreased transepithelial resistance (TER) when HIF-1a was stabilized. Most interestingly, we measured a change in the direction of sodium current, most likely corresponding
to abnormal secretory function, supporting our positive-feedback hypothesis.

doi: 10.14814/phy2.13531
Physiol Rep, 5 (24), 2017, e13531,
https://doi.org/10.14814/phy2.13531

Introduction
Kidney cysts are characterized by epithelial-lined fluid
filled sacs where the fluid is stagnant and loaded with
cytokines (Calvet and Grantham 2001; Cowley et al. 2001;
Grantham 2001; Zheng et al. 2003). By compressing
neighboring tissue, cyst expansion may create localized
ischemia-hypoxia (Bernhardt et al. 2007; Belibi et al.
2011). Cyst expansion is associated with transepithelial
fluid secretion, in contrast to the normal absorptive function (Sullivan et al. 1998). HIF-1a has been shown to
promote cyst expansion through calcium activated

chloride secretion (Buchholz et al. 2013). In order for
kidney cysts to expand, both active (transcellular) ion
transport as well as passive (paracellular) transport may
be altered, possibly converting a normally absorptive
epithelium to a pathological secretory epithelium. It has
been shown that cultured normal kidney cells (MDCK
and primary cultures of human cortical cells) can be
induced to form microcysts via the cAMP pathway
((Mangoo-Karim et al. 1989) and reviewed in (Sullivan
et al. 1998)). Importantly, those studies demonstrated
that abnormalities in either PKD1 or PKD2 genes are not
required to either induce cyst formation or fluid secretion
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by renal epithelial cells: the genetics of kidney cyst disease
are independent of altered epithelial transport.
We hypothesize that, within the context of cystic kidney disease (PKD), stabilized Hypoxia Inducible Factor
(HIF) alters renal epithelial function and encourages cyst
expansion through altered salt and water transport.
Because the genetic defects underlying PKD do not
directly alter epithelial transport, we base our hypothesis
on histological analysis of cystic kidneys showing
increased levels of HIF-1a, HIF-2a, and increased serum
level of Erythropoietin (EPO) (Chandra et al. 1985; Zeier
et al. 1996; Bernhardt et al. 2007; Belibi et al. 2011). In
response to hypoxic conditions, HIF-1a is stabilized and
translocates to the nucleus, resulting in the elevation of
several effector molecules, such as EPO and vascular
endothelial growth factor (VEGF) (Wang and Semenza
1993; Semenza 1999). In the presence of normoxia, HIF1a undergoes hydroxylation by prolyl hydroxylase and
hydroxylated HIF-1a undergoes proteasomal degradation
(Ivan et al. 2001). CoCl2 is well known for its ability to
stabilize hypoxia inducible factor 1a (HIF-1a) (Kaelin
2002; Yuan et al. 2003). CoCl2 was shown to stabilize
HIF-1a by preventing hydroxylation of HIF-1a (Wang
and Semenza 1993; Yuan et al. 2003).
Prior reports have demonstrated changes to transepithelial sodium transport due to fluid flow (Sullivan et al.
1998; Resnick and Hopfer 2007), so we also wished to
determine if flow-driven transport alterations somehow
interact (positively or negatively) with transport changes
caused by stabilized HIF. The rationale for this measurement is provided by the fluid flow alteration within and
in the vicinity of a cyst: flow is slowed or even stopped.
Increased imbibition of water is becoming recognized as a
viable treatment for PKD (Wang et al. 2013), and while
attention has focused on the dilution of the antidiuretic
hormone arginine vasopressin (AVP), increased water
intake also results in higher tubular flow rates, supporting
our hypothesis that fluid flow can impact PKD disease
progression.
Our experimental system consisted of a cultured kidney
epithelial cell line originally microdissected from the cortical collecting duct (mCCD) of an Immortomouse,
chosen because of the particularly simple salt and water
transport system. The kidney collecting duct is known to
“fine tune” salt and water balance in the body, contributing 0.5% the final salt resorption (Fauci 2008; Resnick
2011). In the collecting duct epithelium, sodium ions
enter cells through epithelial sodium channels (ENaC)
localized to the apical membrane and exit the basolateral
side via the transporter protein sodium-potassiumATPase (Na+K+ATPase) (Garty and Palmer 1997; Fauci
2008). Apical and basolateral K+ channels act to clear K+
build up within the cells (Garty and Palmer 1997; Fauci
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2008). Net movement of positive Na+ ions from urine to
blood creates an ionic gradient, driving paracellular transport of negatively charged ions, principally Cl, in the
same direction(Garty and Palmer 1997; Sullivan et al.
1998; Fauci 2008).
Using confluent monolayers of differentiated mouse
kidney epithelia, we experimentally stabilized HIF by
addition of CoCl2 and measured causal changes in
transepithelial transport of sodium and water. We then
compared HIF-stabilized altered transepithelial sodium
transport in the presence or absence of flow. Here, we
report that applying CoCl2 at a concentration commonly
used for HIF stabilization results in altered transcellular
and paracellular transport of salt and water in otherwise
normal renal epithelial cells. We also report that application of fluid flow blunts the alteration of salt and water
transport caused by stabilized HIF.
Because directed transport of salt and water occurs
simultaneously through both paracellular and transcellular
paths, single electrophysiological measurements of
transepithelial currents are unable to distinguish between
the two paths. Thus, we performed two measurements,
one of the transepithelial permeability using FITC-labeled
Dextran molecules (3 kDa and 70 kDa molecular weights)
as paracellular tracers, and one of the transepithelial
amiloride-sensitive sodium current. Two molecular
weights of FITC-Dextran were used because 3 kDa FITCdextran may also be transported via transcellular pathways due to increased fluid-phase transcytosis (Matter
and Balda 2003; Balda and Matter 2007). Because the
paracellular pathway shows a much stronger size selectivity than transcytosis (Matter and Balda 2003), comparing
changes of the two molecular weight FITC-Dextran permeabilities allows us to distinguish between changes to
paracellular transport and changes to transcellular transport.
In summary, to better understand the transport mechanisms for kidney cyst expansion, we performed a series of
measurements on cultured renal epithelia to examine
what changes in transepithelial salt and water transport
may occur when HIF is stabilized and if these changes are
fluid flow-dependent.

Methods
Cell culture
Experiments were carried out on a mouse cell line
obtained by microdissection from the cortical collecting
duct (mCCD 1296 (d)) of a heterozygous offspring
Immortomouse carrying a transgene, temperature-sensitive SV40 large T antigen under the control of an interferon-c response element (Jat et al. 1991). Cells were
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cultured on suspended membrane cell culture inserts. The
mCCD cell line retains the major phenotypic characteristics observed in primary cortical collecting duct cultures
including contact inhibition, tight junction formation, cell
polarity, and directed transport of salt and water.
mCCD cells were grown to confluence under normoxia incubation conditions of 33°C, 5% CO2, during
differentiation cells were incubated at 39°C, 5% CO2.
The growth medium was prepared by combining the following media constituents (final concentrations): Dulbecco’s Modified Eagle Medium (DMEM) w/o glucose
and Ham’s F12 (at a ratio of 1:1), 5 mg/mL transferrin,
5 mg/mL insulin, 10 mg/mL epithelial growth factor
(EGF), 4 mg/mL dexamethasone, 15 mmol/L 4-(2-hydroxyethyl)- 1-piperazineethanesulfonic acid (HEPES), 0.06
w/v% NaHCO3, 2 mmol/L L-glutamine, 10 ng/mL
mouse interferon-c, 50 lmol/L ascorbic acid 2- phosphate, 20 nmol/L selenium, 1 nmol/L 3,39,5-triiodo-Lthyronine (T3), and 5% fetal bovine serum (FBS). Cells
were first expanded on collagen coated 30 mm diameter
suspended membrane cell culture inserts (Millipore
PICM03050, area= 4.71 cm2), inside a 6-well plate (Falcon# 35116). After a sufficient quantity of cells were
obtained, cells were passaged (1:3 dilution) onto 12 mm
diameter suspended membrane cell culture inserts (Millipore PICM 01250, area = 1.13 cm2), within a 24-well
plate (Falcon# 353047), grown to confluence and
allowed to differentiate resulting in a ciliated monolayer
of epithelial cells exhibiting directed salt and water
transport. For differentiation, growth factors (insulin,
EGF, and interferon-c) were omitted from the culture
media and additionally, FBS was omitted from the apical
media.
Figure 1 presents a schematic timeline of our experiments. Day 0 is defined as the starting point, when confluent monolayers were switched to differentiation
conditions. Upon entering differentiation culture conditions, mCCD monolayers develop functional outputs over
time. Directed sodium transport commences and a functional cilium emerges after approximately 5 days. mCCD
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monolayers are considered fully differentiated after
7–10 days, and remain viable for an additional 24 days.
Throughout the experiment, the apical amount of medium was restricted (100 lL), so that the thin fluid layer
could allow sufficient oxygen diffusion (Resnick 2011).

Application of fluid flow
Fluid flow has been shown to alter electrophysiological
properties of renal epithelia (Resnick 2011). Cultures
exposed to fluid flow were placed on an orbital shaker
(Resnick 2011). Fluid flow was generated by operating the
orbital plate shaker (IKA MS3 digital) at 4.2 Hz.

Fluorescein isothiocyanate (FITC)-Dextran
Permeability Assay
Two molecular weight FITC-Dextran molecules (3 kDa
and 70 kDa), anionic, D 3305 and D 1823 (Molecular
Probes, Life Technologies) in Hanks’ Balanced Salt Solution (HBSS), 1X (21-023-CM, Cellgro, Mediatech) were
used to measure the transepithelial permeability. Molecular Probes specifies that the specific lots consist of 1 mole
FITC per mole of Dextran (3 kDa, Lot# 1709577 and
1485224) and 7 moles FITC per mole Dextran (70 kDa,
Lot # 1583589). For both molecular weights, the stock
concentration (120 lmol/L) was serially diluted to eight
different concentrations, ranging from 120 lmol/L to
120 9 108 lmol/L. To generate a fluorescence intensity/
FITC concentration curve, four replicates of 100 lL solution at various concentrations were dispensed into a
96-well plate and fluorescence values were measured using
a fluorescence plate reader (Perker Elmer Life Sciences/
Wallac Victor Multilabel Counter and Wallac 1420 Manager software) using 490 nm excitation and 530 nm emission. Calibration curves were later used to determine the
FITC concentrations from the fluorescence intensity values during permeability experiments.
To perform FITC-Dextran permeability measurements
on our cultures, cell culture inserts were gently washed

Figure 1. Cell culture timeline.
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thrice with HBSS buffer to remove any media. Then,
100 lL of FITC-dextran in HBSS buffer was added to
the apical side and 1 mL of HBSS buffer was added to
the basolateral side of the cell culture inserts. A quantity of 100 lL media samples were collected from the
basolateral side every 10 min, for a total of 70 min, to
measure the transport of FITC-Dextran molecules from
the apical to basolateral side. Each withdrawn sample
was deposited into a 96 well plate, fluorescence intensity value measured, and the sample then added back
to the basolateral side of the culture in order to maintain a constant fluid volume (see below). At the end of
performing the transport experiment with 3 kDa FITCDextran, the cell culture inserts were washed with HBSS
three times and the transport of 70 kDa FITC -Dextran
molecules was determined. For each experiment, the
concentration of initial stock solutions of 3 kDa and
70 kDa FITC -Dextran molecules was determined from
calibration graphs. Each sample replicate was individually plotted in order to calculate permeability values;
the average permeability of 3-5 replicates was calculated
and presented here.

Relationship of permeability to FITC-Dextran
concentration
Because there are many published methods used to determine transepithelial permeability (Siflinger-Birnboim
et al. 1987; Artursson 1990; Abbott et al. 1997; Gaillard
et al. 2001; Matter and Balda 2003; Balda and Matter
2007; Yuan and Rigor 2010), we briefly derive the relationship between time-dependent changes in a tracer
molecule (e.g., FITC-Dextran) and the transepithelial permeability used in our measurement. We wish to emphasize that this derivation does not distinguish between
transcellular and paracellular transport.
Beginning with the equation for mass flux of a tracer
from the apical compartment through a semipermeable
surface (area “A”) to the basolateral compartment (Fick’s
first law) (Fick 1855)
dM bl
¼ P A½CðtÞap  C ðt Þbl 
dt

(1)

where “Mbl” is the total mass of tracer particles in the
basolateral side, “P” the permeability (units length/
time), C(t)ap the time-dependent concentration of tracer
particle on the apical side and C(t)bl the time-dependent concentration of tracer particle on the basolateral
side.
Assuming that the apical and basolateral fluid volumes
remain constant, dividing by the basolateral fluid volume
Vbl and using the conservation of mass M0 = C(t)apVap +
C(t)blVbl, we obtain:
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Vap þ Vbl
dCbl P A M0
 Cðt Þbl
¼
Vbl Vap
dt
Vbl

(2)

Given the initial condition Cbl(0) = 0, this equation has
the solution:



 
1
1
t
(3)
þ
CðtÞbl ¼ C 0 1  Exp PA
Vbl Vap
where C0 is the initial tracer concentration C0 = M0/
(Vap+Vbl). For convenience we define the constant B =
A(1/Vbl + 1/Vap) and rearrange to solve for the permeability:

ln 1  CðtÞbl =C0
(4)
Pt ¼ 
B
Thus, by measuring the basolateral concentration of
FITC-Dextran C(t)bl as a function of elapsed time “t”, we
obtain the permeability “P” as the slope of a best-fit line.
We present our relevant parameter values here in table
form: (Table 1).
Using this approach, the permeability of a cell-free collagen coated cell culture insert was measured to be
(1.21  0.46) 9 105 cm/sec (3 kDa) and (1.01  0.40)
9 106 cm/sec (70 kDa).

Measurement of Transepithelial resistance
and voltage
Transepithelial voltage and resistance measurements were
performed using Endohm chambers (ENDOHM-24SNAP
or ENDOHM-12) from World Precision Instruments
(WPI) connected to an EVOM2 epithelial voltohmmeter
from WPI in voltage-clamp short-circuit mode. Short circuit equivalent current (Ieq) was calculated from voltage
and resistance read outs using Ohm’s law, I = V/R. We
report values of Ieq relative to the control group. More
than 95% of Ieq was inhibited by 10 lmol/L apical
amiloride and thus is considered to be proportional to
the activity of ENaC in the apical plasma membrane.
Before collecting electrophysiological read outs, 100 lL of
apical differentiation media was gently added to cell culture inserts in addition to the 100 lL of apical

Table 1. Permeability calculation parameters.
Parameter
Initial FITC-Dextran concentration C0
Area of semipermeable filter A
Volume of fluid in apical chamber Vap
Volume of fluid in basolateral chamber Vbl
“B” (see equation 4)

Value
Variable
1.13 cm2
100 lL
1 mL
12.43 cm1
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differentiation media already present to ensure electrical
contact between the upper electrodes and apical fluid.

Cobalt chloride treatment
Cobalt chloride (CoCl2) hexahydrate (S93179 from Fisher
Scientific) was dissolved in 1X Phosphate Buffer Saline
(PBS) buffer to make 100 mmol/L CoCl2 stock solution,
which was further diluted in cell culture media to achieve
the desired concentration of 100 lmol/L. Experiments
were performed with CoCl2 added to apical differentiation media (APDM), basolateral differentiation media
(BLDM), or to both APDM and BLDM.

Cobalt Chloride Alters Renal Epithelial Function

concentration of 1:100, mouse monoclonal sodium-potassium ATPase (NaKATPase) a1 subunit (Developmental
Studies Hybridoma Bank at University of Iowa# a6F at a
concentration of 1:600. Secondary HRP conjugated anti
mouse antibody was used at a concentration of 1:2000. To
compare b-actin levels in the membrane which were first
analyzed for EPO levels, a stripping buffer, Restore Plus
Western Blot Stripping Buffer from Thermo scientific (product no. 46430) was used. Antibodies were stripped from
the membrane for 10 min, followed by washing with TBST
and the membrane was blocked again before addition of
primary antibody, that is, monoclonal beta actin antibody.
LI-COR Image StudioTM Software was used to perform densitometric analysis of western blot results.

Cell lysate preparation
Whole cell lysates were prepared using RIPA 1X cell lysis
buffer. The 10X RIPA buffer from Cell Signaling Technology (Product no. 9806) was first diluted to prepare 1X
buffer. The Halt Protease Inhibitor Cocktail from Thermo
Scientific (Product no. 78430) was added at a final concentration of 1X. The RIPA buffer cell lysis protocol from
Cell Signaling Technology was followed to prepare whole
cell lysates. The EPO levels were compared in the whole
cell lysates.
Nuclear extracts were prepared using NE-PER Nuclear
and Cytoplasmic Extraction Reagents from Thermo Scientific (Product no. 78833). The Halt Protease Inhibitor
Cocktail was added to during the extraction as instructed
by the manufacturer. The protocol from Thermo Scientific was followed to obtain nuclear extracts. The HIF1a
levels were compared in the nuclear extracts.
The protein concentrations in each sample were determined using Bradford assay using Coomassie Plus Protein
Assay Reagent from Thermo Scientific (Product No.
1856210). In each well of the gel same amount (lg) of
proteins were loaded. Before loading the samples in the
wells of the polyacrylamide gels, sample buffer was added
and samples were heated for 6 min at 95°C.

Western blot
SDS-PAGE: 12% acrylamide-bisacrylamide gels and 4%
stacking gels were used. The following antibody concentrations were used: mouse monoclonal b-actin (Novus Biologicals# NB600-501) at a concentration of 1:10,000, mouse
monoclonal HIF1a (Santa Cruz # sc-13515) at a concentration of 1:200, mouse monoclonal EPO (Santa Cruz
Biotechnology# sc80995) at a concentration of 1:200,
mouse monoclonal GAPDH (Santa Cruz Biotechnology#
sc-166545) at a concentration of 1: 1000, rat monoclonal
zonula occludin 1 (ZO-1) (Developmental Studies Hybridoma Bank at University of Iowa# R26.4C) at a

MTT cell viability assay
Cell Titer 96 Non-Radioactive Cell Proliferation Assay
(MTT), G4000 (Promega) was used to determine if cell viability was altered by the addition of CoCl2. Sample absorbance values were measured at 570 nm using an absorbance
plate reader (Perker Elmer Life Sciences/Wallac Victor Multilabel Counter and Wallac 1420 Manager Software). Using
trypan blue dye and a hemocytometer, cell enumeration
was performed and a calibration graph was generated from
cell seeding densities and absorbance values.

Statistical analysis
Using Microsoft Excel, a type three (two-sample unequal
variance, heteroscedastic) and a two-tailed Student’s t-test
was performed between the groups to determine the level
of any significance difference. IBM-SPSS software was
used to perform One-way ANOVA with post hoc Tukey
to make comparisons among more than two groups.
Standard errors were calculated from standard deviation
values and are shown in the graphs.

Results
Application of 100 lmol/L CoCl2 increases
HIF1a levels
We performed western blots to demonstrate that addition
of 100 lmol/L CoCl2 to our culture media significantly
increased nuclear HIF-1a and slightly increased HIF-1a
effector molecule erythropoietin (EPO) in the whole cell
extracts. The findings are in agreement with prior reports
(Fisher and Langston 1967; Fandrey et al. 1997; Verghese
et al. 2011). Stabilization of HIF1a resulted in significant
decrease in the levels of ZO-1 and NakATPase, a1 subunit. Western blots and densitometric analysis are shown
in Figure 2.
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Figure 2. (A) shows western blots of nuclear extracts of mCCD cells treated with 100 lmol/L CoCl2. Treatment with CoCl2 increased
stabilization of HIF1a in the nucleus of the cells. GAPDH levels are shown as loading controls. (B) shows western blots of whole cell extracts of
mCCD cells treated with 100 lmol/L CoCl2 for 4 h. As shown in the images, treatment with CoCl2 increased the EPO production by cells. Beta
actin levels are shown as loading controls. (C) shows western blots of whole cell extracts of mCCD cells treated with 100 lmol/L CoCl2 for 4 h
and chronic fluid flow. As shown in the images, treatments decreased ZO-1 production by cells independently of fluid flow stimulation. Beta
actin levels are shown as loading controls. (D) shows western blots of whole cell extracts of mCCD cells treated with 100 lmol/L CoCl2 for 4 h
and chronic fluid flow. As shown in the images, treatments decreased NaKATPase production by cells independently of fluid flow stimulation.
Beta actin levels are shown as loading controls. (E) Densitometric analysis of Western blots presented in (A–D). HIF1a level: P = 0.004 (N = 3),
t-test, showing significant nuclear stabilization of HIF1a. EPO level: increases slightly though not statistically significant (N = 3, P > 0.05, Oneway ANOVA). ZO-1 level: P < 0.0001 (N = 4), One-way ANOVA, showing significant decrease in ZO-1 levels, independent of fluid flow.
NaKATPase a1 subunit level: P = 0.001 (N = 3), One-way ANOVA, showing significant decrease in NaKATPase a1 subunit levels, largely
independent of fluid flow.

Effect of Cobalt Chloride on cell viability
The MTT (MTT 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) assay is a colorimetric assay for
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assessing cell metabolic activity and reflects the number of
viable cells present (Meerloo et al. 2011). Growing cells,
being more active, have higher mitochondrial dehydrogenase activity and show higher MTT absorbance values.
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As shown in Figure 3, MTT absorbance values showed
that there were no significant differences between control
and CoCl2 treatment groups either in the presence or
absence of fluid flow, indicating that addition of
100 lmol/L CoCl2 to our culture media did not affect
cellular viability.

Transepithelial Permeability
As mCCD epithelial cells differentiate, they form tight
junctions and tissue-level gain-of-function properties
such as directed transport of salt and water begin to
emerge. Figure 4A presents transepithelial permeability
data of mCCD monolayers during this differentiation
process. As expected, permeability at day 1 was significantly higher as compared to fully differentiated mCCD
monolayers after 10 days of differentiation. This measurement provides some evidence that the principal diffusion path for 3 kDa FITC-Dextran in mCCD cells
may be via paracellular route, as tight junctions form
early in the differentiation process. In contrast, the permeability of 70 kDa FITC-Dextran showed no changes
during differentiation (Fig. 4B). During later phase of
differentiation 3 kDa and 70 kDa permeability values
were stable.
Once fully differentiated, mCCD monolayers showed
3 kDa FITC-Dextran permeability of (1.9  1.5) 9
108 cm/s and 70 kDa FITC-Dextran permeability of
(2.2  1.9) 9 109 cm/sec (Fig. 5). Both of these are significantly reduced as compared to the cell-free insert,
demonstrating the efficacy of tight junctions in regulating
transcellular transport.

Cobalt Chloride Alters Renal Epithelial Function

CoCl2 increases monolayer permeability:
We investigated the effect of CoCl2 in altering monolayer
permeability. Addition of 100 lmol/L CoCl2 to fully differentiated monolayers for 48 h increased 3 kDa FITCDextran permeability to (4.02  3.15) 9 107 cm/s and
addition of 100 lmol/L CoCl2 for 72 h increased the permeability further to (9.05  8.13) 9 107 cm/s (Fig. 6A).
Similarly, the transepithelial permeability of 70 kDa
FITC-Dextran was (1.99  2.13) 9 108 cm/s at 48 h
and (7.24  6.47) 9108 cm/s at 72 h (Fig. 6B). That is,
CoCl2 increased 3 kDa dextran-fluorescein permeability
more than 100-fold and 70 kDa dextran-fluorescein permeability nearly 40-fold. In conclusion, CoCl2 was found
to significantly increase the transepithelial permeability of
FITC-Dextran molecules through fully differentiated
mCCD monolayers.

Transepithelial electrophysiology
Results:
Transepithelial resistance
Due to tight junctions, an untreated confluent and fully
differentiated mCCD monolayer has a transepithelial
resistance (TER) value around 3 kO-cm2. As shown in
Figure 7A and B, extended application of CoCl2 results
in a significant decrease in the TER value at day 2 and
3, consistent with the measured increase in transepithelial permeability. After 72 h with CoCl2 treatment,
the TER of mCCD monolayers were found to decrease
fourfold in the absence of fluid flow and threefold
in the presence of fluid flow. Statistical analysis shows
that the effect of HIF stabilization in decreasing monolayer resistance was enhanced when fluid flow was
absent.

Transepithelial Equivalent short-circuit
current Ieq

Figure 3. Shows that MTT absorbance values do not significantly
change with addition of CoCl2, indicating cell viability is unchanged
due to 3 days of treatment, either in the presence or absence of
fluid flow. N = 4–5. One Way ANOVA, non-significant, P > 0.05.

Figure 8 shows that the effect of CoCl2 on Ieq measurements was more prominent in the absence of fluid flow
as compared to monolayers cultured in the presence of
fluid flow. In response to CoCl2 treatment, significant
decreases of Ieq values were found after 30 h in the
absence of flow (Fig. 8A). In response to CoCl2 treatment
for 3 days in monolayer cultures not exposed to fluid
flow, Ieq values showed a significant change and, very significantly, a positive mean Ieqvalue of 0.9 lA/cm2 was
developed. Movement of positive sodium ions from the
apical to basolateral side results in a negative Ieq value.
Thus, a positive Ieq value implies that net ion transport
may be moving in the opposite direction. It is tempting
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Figure 4. (A) Shows that 3 kDa FITC dextran transepithelial permeability at the onset of differentiation (day 1) is significantly higher as
compared to fully differentiated mCCD monolayers (day 10). N = 3–6. One-way ANOVA P < 0.002. (B) shows that the permeability of 70 kDa
FITC-dextran does not change significantly during differentiation. N = 3–6, One-way ANOVA P > 0.05.

Figure 5. Shows the transepithelial permeability of fully
differentiated mCCD monolayers. N = 8. T-test: P value < 0.02.

to interpret these results as confirmation of our hypothesis that increased levels of HIF can transform a normally
absorptive epithelial monolayer into a secretory
monolayer.
Comparison of normalized Ieq values of mCCD monolayers cultured with chronic fluid flow showed that Ieq
values significantly decreased at day 2 in response to
CoCl2 treatment as shown in Figure 8B. Control samples
had a mean Ieq value of 2.6 lA/cm2, whereas CoCl2treated samples showed mean Ieq values of 0.1 lA/cm2
(48 h) and 0.2 lA/cm2 (72 h).

Figure 6. (A) CoCl2 added on day 22. Data shows that CoCl2 treatment for 48 h (Day 24) and 72 h (Day 25) increased the permeability of
differentiated mCCD monolayers measured with 3 kDa FITC-dextran. N = 4–5, One-way ANOVA. CoCl2 treatment significantly (P value = 0.02)
increases monolayer permeability on day 25. No other statistical significant difference was noticed among any other groups. (B) CoCl2 added
on day 22. Data shows that CoCl2 treatment for 3 days increased the permeability of differentiated mCCD monolayers measured with 70 kDa
FITC-dextran. N = 4–5, One-way ANOVA. CoCl2 treatment significantly (P value = 0.02) increases monolayer permeability on day 25. No other
statistical significant difference was noticed among any other groups.
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Figure 7. CoCl2 added to mCCD cultures on day 24 in the absence (A) or presence (B) of chronic steady flow. N = 4–16. Data shows that
application of 100 lmol/L CoCl2 significantly decreased TER values of differentiated mCCD monolayers after 48 h (2 days) without fluid flow.
One-way ANOVA shows no significant (P > 0.05) TER changes among control groups in (A) or (B). ‘*’ denotes significant change (P < 0.05)
between a control and CoCl2 treatment at a specific time-point. ‘#’ denotes significant change (P < 0.05) between CoCl2-treated sample at
one time point with CoCl2-treated or control sample at other time points. No statistical difference was found between CoCl2 treatment on day
26 and day 27 in (A). In figure (B) with fluid flow, at a specific time point, statistical significance (P > 0.05) was not detected between control
and CoCl2. However, we noticed CoCl2 treatment group value was significantly decreased as compared to control value at a different time
point (P < 0.05, denoted by #). TER on day 27 of CoCl2-treated group was significantly decreased as compared to Day 26 control. Similarly,
TER on day 26 of CoCl2-treated group was significantly decreased as compared to Day 25 control.

Comparing Figures 8A and B, it should be noted that
CoCl2 altered Ieq values in the monolayers without fluid
flow were significantly altered after 30 h, whereas in the
monolayers cultured with fluid flow, significant changes
occurred after 48 h. Therefore, it can possibly be inferred
that the lack of fluid flow can intensify the effect of HIF
stabilization.

CoCl2 Acts on Basolateral side
In our cell lines, the transporter responsible for couptake
has not been clearly identified. In mammalian cells, the
divalent metal cation transporters Slc11a1 and Sla11a2
may be responsible for couptake (Gunshin et al. 1997;
Forbes and Gros 2003). We found that mCCD monolayers cultured in flow exposed to apical CoCl2 treatment
showed an initial, transient, increase in TER but no
chronic change to the TER. The Ieq values mostly
remained unaffected except for a transient change on day
23 in culture (i.e., 5 days of CoCl2 treatment), shown in
Figure 9. However, when CoCl2 was added only to the
basolateral media, we noted significant dose-dependent
decreases in both TER and Ieq values, shown in Figure 10.
Basolateral treatment with 100 lmol/L CoCl2 showed significant decreases in TER values after 2 days of treatment
as shown in Figure 10A. Thus, it is interesting to find
that CoCl2 affects the electrophysiological properties of

our monolayers only when it is added in the basolateral
media, potentially identifying the site of couptake.

Discussion
100 lmol/L CoCl2 stabilizes HIF-1a without
affecting cell viability
In our mCCD monolayers 100 lmol/L CoCl2 was found
to significantly stabilize HIF-1a in the nucleus and also
resulted in a slight increased production of EPO, not statistically significant. 100 lmol/L CoCl2 was previously
reported to stabilize HIF1a in the nucleus of MadinDarby Canine Kidney (MDCK) epithelial cells (Verghese
et al. 2011). Other studies showed cobalt can increase
EPO production (Fisher and Langston 1967; Fandrey
et al. 1997). CoCl2 was previously shown to prevent cell
growth of mouse embryonic fibroblasts at a concentration
of 100 lmol/L. However, our MTT assay showed
100 lmol/L CoCl2 did not have any significant effect on
the cell viability of the fibroblasts after 72 h (Vengellur
and LaPres 2004). Similarly, we did not notice any change
in the cell viability levels of mCCD kidney epithelial cells
by 100 lmol/L CoCl2.
As mentioned previously, in kidney cystic epithelia of
rats and humans HIF-1a protein level and mRNA levels
of HIFa target genes, such as EPO, glucose transporter-1
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Figure 8. (left) without applied flow; (right) with applied flow. CoCl2 added on day 24. Data shows that application of 100 lmol/L CoCl2
significantly decreased Ieq values of differentiated mCCD monolayers after 48 h (2 days). Interestingly, after 3 days of treatment, Ieq value
switched to the positive direction. Current values are plotted as relative to average Ieq values as discussed in the main text. N = 4–16. One-way
ANOVA shows no significant (P > 0.05) Ieq changes among control groups in (A) or (B). * denotes significant change (P < 0.05) between a
control and CoCl2 treatment at a specific time-point. # denotes CoCl2 treatment causes significant change (P < 0.05) between CoCl2-treated
sample at a specific time point with CoCl2-treated or control sample at a different time point. In Figure (A) and (B), CoCl2 treatment shows
gradual decrease in negative Ieq; some of this gradual decrease was statistically significant (e.g., Figure (A) Day 25 CoCl2 vs. Day 26 CoCl2).

(Glut-1), and vascular endothelial growth factor (VEGF)
were found to be elevated (Bernhardt et al. 2007). Using
CoCl2 we stabilized HIF-1a in our kidney epithelial
monolayers to better understand potential roles of ischemia-hypoxia or otherwise HIF stabilized environment as
experienced by normal kidney epithelial cells in an
ischemic environment created by the presence of cysts in
PKD.

Effect of Fluid Flow with HIF stabilization
Our electrophysiological results suggest that the presence
of fluid flow may blunt HIF-stabilized altered transepithelial transport. For example, both Ieq and TER values
decreased more rapidly in the absence of fluid flow as
compared to monolayers cultured in the presence of
chronic fluid flow.
While it is tempting to suggest that monolayers cultured
in the absence of fluid flow may be hypoxic to some extent
and may already have increased HIF to some extent, our
use of thin apical fluid thickness ensures adequate O2 transport to the monolayer. Two possible alternative
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explanations for more prominent effects of CoCl2 in cultures lacking fluid flow are (1) the level of stabilized HIFa
by CoCl2 may be higher in cultures lacking fluid flow, or
(2) CoCl2 can stabilize HIFa in the cultures without fluid
flow at an earlier time point as compared to cultures with
fluid flow. We tried to directly measure alterations of HIF
levels via Western blot, but our bands were too faint to provide meaningful results. We compared EPO levels but
could not detect any statistically significant difference
between CoCl2 treated with or without fluid flow. Moreover, comparing ZO-1 and NaKATPase a1 subunit levels,
we could not detect any statistically significant difference
due to HIF-1a stabilization with or without fluid flow.
Taken together, this implies that the examined epithelial
response to fluid flow is independent of HIF-1a.

HIF Stabilization by CoCl2 alters transcellular
and paracellular transport
In the mammalian kidney, paracellular permeability is
known to decrease from proximal tubule to collecting
duct due to the unique expression of claudins and higher
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Figure 9. CoCl2 added to apical media on day 18. Data shows that application of CoCl2 in apical media does not cause a significant chronic
change in (top) TER values or (bottom) Ieq values of differentiated mCCD monolayers. N = 5–8. In the TER and Ieq data, One-way ANOVA
shows no significant (P > 0.05) TER and Ieq changes among control groups. In the TER plot, * denotes significant change (P < 0.05) among
0 lmol/L CoCl2, 50, and lmol/L 100 CoCl2 treatment at a specific time-point. # denotes CoCl2 treatment causes significant change (P < 0.05)
between CoCl2-treated sample at a specific time point with CoCl2-treated or control sample at a different time point. Not all significance (#)
are shown in the graph; all # are marked onto any noticeable change and applicable to group treated with CoCl2. There is no significant effect
(P > 0.05) of apical application of 0, 50, or 100 lmol/L CoCl2 on Ieq.

levels of occludin and zonula occludin-1 (ZO-1) (Gonzalez-Mariscal et al. 2000; Denker and Sabath 2011). Paracellular transport through epithelial tight junctions is
driven by the ion gradient created due to transcellular
active transport. In our mCCD monolayers HIF stabilization for 72 h with CoCl2 resulted in a 100 fold increase
in 3 kDa FITC-dextran permeability and 40 fold increase

in 70 kDa FITC -dextran permeability. Thus, paracellular
transport through tight mCCD monolayers was found to
increase due to HIF stabilization.
Epithelial tight junctions maintain the high electrochemical gradient created by transcellular transport
(Anderson and Van Itallie 2009). High TER values generally correspond to low paracellular flux and low TER
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Figure 10. CoCl2 was withdrawn from apical media and added to basolateral media on day 25. Data shows that application of 100 lmol/L
CoCl2 to basolateral media significantly decreased (left) TER values and (right) Ieq values of differentiated mCCD monolayers in a dosedependent manner after 2 days of treatment (N = 5–6). In the TER and Ieq data, One-way ANOVA shows no significant (P > 0.05) TER and Ieq
changes among control groups. In the TER plot, * denotes significant change (P < 0.05) among 0 lmol/L CoCl2, 50, and lmol/L 100 CoCl2
treatment at a specific time-point. # denotes CoCl2 treatment causes significant change (P < 0.05) between CoCl2-treated sample at a specific
time point with CoCl2-treated or control sample at a different time point. In figure (A) we do not see statistically significant decrease in TER,
* (P < 0.05) on day 27 or day 28 by 50 or 100 lmol/L CoCl2 as compared to control (0 lmol/L CoCl2) on that specific day. However, we
notice some significant decrease in TER as compared to control at a different time point. For example on day 28, 100 lmol/L CoCl2 causes
significant decrease in the TER value when compared to 0 lmol/L CoCl2 TER value on day 27, denoted by #. In figure (B) we notice significant
loss of Ieq with 100 lmol/L CoCl2 treatment on day 27 and significant loss of Ieq with both 50 and 100 lmol/L CoCl2 treatment on day 28. Not
all significance (#) are shown in the graph; all # are marked onto any noticeable change and applicable to group treated with CoCl2.

values generally refer to monolayers with high paracellular
flux. mCCD monolayers show high TER values, around 3
kO-cm2. Increased FITC-dextran permeability is consistent with decreased TER values due to HIF stabilization.
The cortical collecting duct is responsible for 0.5% salt
reabsorption and helps in fine-tuning water and salt balance in the body. mCCD Ieq is primarily generated by
sodium transport through ENaC channels and 95% of Ieq
can be blocked by 10 lmol/L amiloride, a sodium channel blocker (Resnick and Hopfer 2007; Resnick 2011). We
noticed that HIF stabilization by CoCl2 caused decreased
Ieq values, indicating mainly the loss of active sodium
transport.
Similar observations to our results were made studying
the effect of hypoxia on aleveolar epithelial cells
(Mairb€aurl et al. 2002). Hypoxia was found to decrease
active sodium transport through rat alveolar epithelial
monolayers and also decreased TER of monolayers,
increasing permeability of 4 kDa dextran-FITC through
the epithelial monolayers (Mairb€aurl et al. 2002; Bouvry
et al. 2006). Hypoxia was found to decrease ZO-1 protein
levels in the same alveolar monolayer (Bouvry et al.
2006). Hypoxia can affect the actin cytoskeleton
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organization and can result in occludin mislocalization
from tight junctions to the cell interior (Bouvry et al.
2006). Hypoxia was shown affect the expression or activity of apical ENaC and basolateral NaKATPase causing
decrease in active sodium transport, resulting in reduced
ability of alveolar epithelium to clear alveolar edema fluid
(Vivona et al. 2001; Planes et al. 2002; Dada et al. 2003).
Hypoxia was shown to alter tight junctions and permeability of other cell types, such as brain microvessel
endothelial cells and intestinal epithelial cells (Xu et al.
1999; Yamagata et al. 2004; Engelhardt et al. 2014), supporting our findings that HIF stabilization can decrease
monolayer resistance and can increase FITC-dextran permeability. Similarly, our western blots showed that stabilization of HIF1a by CoCl2, decreased levels of ZO-1 and
NaKATPase a1 subunit independent of fluid flow.
Our measurements demonstrating altered transepithelial permeability is relevant is supported by other results
demonstrating that epithelial tight junction morphology
is regulated by HIF, with claudins (Saeedi et al. 2015)
and occludins (Caraballo et al. 2011) being specific targets. Similarly, our electrophysiological measurements are
in concordance with other results (Caraballo et al. 2011).
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Stabilization of HIF1a by CoCl2 results in decreased
TER values of mCCD monolayers corresponding to
increased permeability of 3 kDa and 70 kDa dextranfluorescein. 3 kDa dextrans can be transported through
epithelial monolayers either by fluid-phase transcytosis or
by paracellular transport, whereas large 70 kDa dextran
molecules are known to be transported only through the
paracellular pathway (Matter and Balda 2003). Thus,
changes in 70 kDa transport through mCCD monolayers
represent changes in the paracellular pathway.
Using 3 kDa and 70 kDa FITC-Dextran molecules, we
were able to identify that the size selectivity was maintained by mCCD epithelial monolayer tight junctions.
Increased permeability of anionic FITC-dextran from apical to basolateral side suggests increased paracellular
transport which can also be indicative of increased water
permeability.

Conclusion
In summary, in mCCD monolayers, we noted that HIF
stabilization by CoCl2 caused loss of Ieq and may show a
positive Ieq value in the absence of fluid flow, indicating
that the net flux of sodium ions may be transported in
the opposite direction and thus those epithelial monolayers may be secretory rather than absorptive. In mCCD
monolayers HIF stabilization showed a significant
decrease in the TER values and increase in 70 kDa permeability due to paracellular pathway changes. Thus, HIF
stabilization seems to affect both the transcellular and
paracellular pathways of kidney epithelial monolayers.
Increased FITC-dextran permeability through cellular
monolayers of mCCD indicated altered selective epithelial
barrier function. Decreased levels of tight junction protein, such as ZO-1 causes decreased resistance and
increased paracellular permeability of epithelial monolayer. Decreased levels of basolateral enzyme NaKATPase
can be at least partly responsible for the loss of transcellular transport of sodium ions. Moreover, we identified that
CoCl2 uptake may occur via basolateral side of
monolayers.
In conclusion, we have provided preliminary evidence
in support of our hypothesis that HIF stabilization can
contribute to kidney cyst expansion by increasing tissue
permeability and reversing net sodium transport through
normal kidney epithelia. We suspect this path may also
involve cAMP, as increased levels of cAMP are associated
with microcysts. It has been shown that HIF-1a contains
a cAMP-response element binding (CREB) binding site
(Kvietikova et al. 1995). It has also been shown that HIF1a accumulates via the cAMP-mediated induction of the
mTOR pathway in beta cells (Van de Velde et al. 2011),
but we did not directly test the role of cAMP in our cells.
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